Benzocaine

This classification denotes an anesthetic agent with the molecular formula C9H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U3RSY48JW5, chemically known as 4-aminobenzoic acid, ethyl ester but generally known as benzocaine, which bears US NIH Compound Identifier 2337. Benzocaine most often comes in base, oxalate, silicon, and succinate forms. European Medicines Agency schedules Benzocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05755MIG. The term BENZOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules benzocaine in its Anatomical Therapeutic Chemical (ATC) Classification. BENZOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzocaine under HS 29224995 and SITC 51465. As of Q4 2014, BENZOCAINE remains the US FDA Preferred Term for this commodity. Benzocaine bears US NLM identifiers UMLS ID C0005059 and NCI Concept Code C28923. SMILES: O(C(=O)C1CCC(N)CC1)CC.